Related Experiment Video

Updated: May 25, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

Stefan P Glaser1, Erinna F Lee, Evelyn Trounson

  • 1The Walter and Eliza Hall Institute, Parkville, Melbourne, Victoria 3052, Australia.

Genes & Development
|January 27, 2012
PubMed

Insights

Targeting Mcl-1, a key protein in acute myeloid leukemia (AML) survival, offers a promising new therapeutic strategy. Eliminating Mcl-1 effectively combats drug-resistant AML and cures the disease in mice.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myeloid leukemia (AML) often relapses after initial treatment.
  • Drug resistance in AML is frequently linked to elevated levels of anti-apoptotic Bcl-2 family proteins, specifically Bcl-x(L) and Mcl-1.

Purpose of the Study:

  • To investigate the critical role of specific Bcl-2 family members in the survival of acute myeloid leukemia cells.
  • To determine if targeting Mcl-1 or other Bcl-2 family members can overcome drug resistance and treat AML.

Main Methods:

  • Utilizing selective inhibitors of prosurvival Bcl-2 family members.
  • Assessing the impact of Mcl-1 removal versus blockade of Bcl-x(L), Bcl-2, or Bcl-w on AML cell death.
  • Evaluating therapeutic efficacy in mouse models of AML.

Main Results:

  • Removal of Mcl-1 induced cell death in transformed AML cells.
  • Loss or blockade of Bcl-x(L), Bcl-2, or Bcl-w did not significantly impact AML cell survival.
  • Targeting Mcl-1 cured AML in afflicted mice, demonstrating its critical role in human AML cell survival.

Conclusions:

  • Mcl-1 is essential for the survival of human acute myeloid leukemia cells.
  • Targeting Mcl-1, or its regulatory pathways, represents a potentially effective therapeutic strategy for treating AML.
  • Unlike other Bcl-2 family members, Mcl-1 is the critical determinant for AML cell viability.

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...